Clinical Trial: SWOG S1706

SWOG S1706

Status: Closed

A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer

S1706 is closed to accrual on July 1, 2024.